Crown (CCK) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Oct, 2025Executive summary
Third quarter 2025 results exceeded expectations, with adjusted EPS up 13% year-over-year and net income of $214 million, reversing a prior year loss.
Net sales for Q3 2025 were $3,202 million, up from $3,074 million in Q3 2024; nine-month net sales reached $9,238 million.
Over $400 million was returned to shareholders in the first nine months through buybacks and dividends.
Achieved long-term net leverage target of 2.5x at September 30, 2025.
Focus remains on profitable growth, cash flow generation, and disciplined capital allocation.
Financial highlights
Adjusted EPS for Q3 2025 was $2.24, up from $1.99 in the prior year; reported EPS was $1.85 versus a loss of $1.47.
Segment income reached $490 million, up from $472 million; operating income was $423 million, down from $444 million.
Adjusted free cash flow for the first nine months was $887 million, up from $668 million; cash from operations was $1,043 million.
Cash and cash equivalents at September 30, 2025, were $1,172 million, up from $918 million at year-end 2024.
Over $400 million returned to shareholders year-to-date through buybacks and dividends.
Outlook and guidance
Full-year 2025 adjusted EPS guidance raised to $7.70–$7.80; Q4 adjusted EPS expected at $1.65–$1.75.
2025 adjusted free cash flow projected at $1 billion after $400 million in capital spending.
Net leverage to remain near 2.5x; adjusted effective tax rate expected at 25%.
Capital spending for 2025 is expected to be approximately $400 million.
Net interest expense expected at $350 million, depreciation at $310 million.
Latest events from Crown
- Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing23 Mar 2026 - Record EBITDA, strong cash flow, and improved leverage drive positive 2026 outlook.CCK
Q4 20255 Feb 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026 - Record EBITDA, strong cash flow, and reduced leverage highlight a positive 2025 outlook.CCK
Q4 20248 Jan 2026 - Q1 net income up to $193M, adjusted EPS up 64%, and guidance raised on strong can demand.CCK
Q1 20256 Jan 2026 - Board backs director elections, auditor, and pay, but opposes political spending disclosure proposal.CCK
Proxy Filing1 Dec 2025 - Q2 adjusted EPS up 19%, sales and cash flow strong, and guidance raised for the year.CCK
Q2 20254 Nov 2025